Revance Therapeutics Income Statement

Financials in millions PKR. Fiscal year is January - December.

Millions PKR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Premiums & Annuity Revenue	12.08	7.54	-	-	-	-	Upgrade
Total Interest & Dividend Income	13.38	11.64	6.38	5.73	5.62	7.27	Upgrade
Other Revenue	0.75	0.75	-	-	-	0	Upgrade
Total Revenue	26.21	19.93	6.38	5.73	5.62	7.27	Upgrade
Revenue Growth (YoY)	327.58%	212.49%	11.30%	1.94%	-22.65%	-	Upgrade
Policy Benefits	4.26	2.95	-	-	-	-	Upgrade
Policy Acquisition & Underwriting Costs	6.79	2.84	-	-	2.08	2.87	Upgrade
Depreciation & Amortization	2.84	2.84	6.04	6.57	18.35	21.1	Upgrade
Selling, General & Administrative	26.35	25.45	47.5	27.25	39.45	24.7	Upgrade
Other Operating Expenses	2.21	0.09	-	-	-	-	Upgrade
Total Operating Expenses	44.12	35.83	56.48	37.29	63.58	54.67	Upgrade
Operating Income	-17.91	-15.9	-50.1	-31.56	-57.96	-47.4	Upgrade
Other Non Operating Income (Expenses)	-0.14	-0.11	-0.05	-0.04	-0.05	0.19	Upgrade
EBT Excluding Unusual Items	-18.04	-16.01	-50.15	-31.6	-58.02	-47.21	Upgrade
Gain (Loss) on Sale of Assets	0.02	0.02	0.11	1.88	5.99	5.42	Upgrade
Asset Writedown	47.38	47.38	117.82	-2.3	24.01	-	Upgrade
Other Unusual Items	-	-	-	2.33	33.03	-	Upgrade
Pretax Income	29.35	31.38	67.78	-29.7	5.02	-41.79	Upgrade
Income Tax Expense	-0.28	-0.42	-2.67	-0.9	-8.07	-	Upgrade
Net Income	29.63	31.8	70.46	-28.79	13.09	-41.79	Upgrade
Net Income to Common	29.63	31.8	70.46	-28.79	13.09	-41.79	Upgrade
Net Income Growth	-56.10%	-54.86%	-	-	-	-	Upgrade
Shares Outstanding (Basic)	51	50	46	46	46	46	Upgrade
Shares Outstanding (Diluted)	51	50	48	46	46	46	Upgrade
Shares Change (YoY)	5.47%	3.61%	4.00%	-	-	-	Upgrade
EPS (Basic)	0.58	0.64	1.52	-0.62	0.28	-0.90	Upgrade
EPS (Diluted)	0.58	0.64	1.46	-0.62	0.28	-0.90	Upgrade
EPS Growth	-58.38%	-56.43%	-	-	-	-	Upgrade
Free Cash Flow	-11.27	-11.99	-47.57	-20.02	-21.82	-19.92	Upgrade
Free Cash Flow Per Share	-0.22	-0.24	-0.99	-0.43	-0.47	-0.43	Upgrade
Operating Margin	-68.33%	-79.79%	-785.62%	-550.92%	-1031.32%	-652.42%	Upgrade
Profit Margin	113.06%	159.60%	1104.86%	-502.53%	232.87%	-575.20%	Upgrade
Free Cash Flow Margin	-42.98%	-60.17%	-745.94%	-349.48%	-388.20%	-274.22%	Upgrade
EBITDA	-16	-13.06	-44.05	-24.99	-39.61	-26.56	Upgrade
EBITDA Margin	-61.05%	-65.53%	-	-	-	-	Upgrade
D&A For EBITDA	1.91	2.84	6.04	6.57	18.35	20.84	Upgrade
EBIT	-17.91	-15.9	-50.1	-31.56	-57.96	-47.4	Upgrade
EBIT Margin	-68.33%	-79.79%	-	-	-	-	Upgrade

Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.